Promacta eltrombopag regulatory update

Ligand said FDA granted Priority Review to an sNDA from GlaxoSmithKline for Promacta eltrombopag to treat thrombocytopenia in adults with chronic HCV infection. GSK submitted the sNDA in May. A 6-mont...